MarketResearchReports.Biz

The left atrial appendage (LAA) is a small ear-shaped sac in the muscle wall of the top left chamber of the heart that controls the electrical impulses during atrial fibrillation. LAA closure device is an interventional device used to prevent stroke, reduce the risk of secondary stroke and emboli because of atrial fibrillation. The global left atrial appendage closure market is expected to grow at a massive CAGR of over 28% during the forecast period.

Numerous factors drive the left atrial appendage closure market, but one of the main factors is the significant increase in the incidences of stroke. It is estimated that around 15 million people suffer a stroke every year across the globe. With the rise in the aging population, excessive smoking, average hypertension, and cholesterol levels, the number of atrial fibrillation cases is also increasing globally.

Segmentation by product and analysis of - epicardial LAA closure and endocardial LAA closure
The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Epicardial LAA closure device
Endocardial LAA closure device

Endocardial involves implantation of a device to occlude the LAA. Endocardial LAA closure devices are implanted through a transseptal approach under TEE technique. A specific delivery system has been developed for each device type allowing for repositioning, collapse, or removal in the event of suboptimal results.

Download Sample Copy Of This Report @ http://www.marketresearchreports.biz/sample/sample/489787

Geographical segmentation and analysis of - Americas, APAC, EMEA
The EMEA region is the highest revenue generator in the left atrial appendage closure market in 2015, accounting for about 52% share, and then followed by the APAC region. The market in the EMEA is expected to continue its growth during the forecast period and this is attributed to increase in the incidence of strokes and the growing elderly population. Stroke alone accounts for 1.1 million deaths in Europe every year.

The report offers an analysis of each of the following segments and discusses its impact on the overall market growth -

Americas
APAC
EMEA

Competitive landscape and key vendors - AtriCure, Boston Scientific, St. Jude, Coherex Medical
The LAA closure market witness the presence of very few market vendors, hence the competition in the market is moderate at present. However, the competition is expected to intensify with new product launches. Also, there is a vast opportunity for the market to grow significantly in the Americas in the forecast period.

Primary vendors in this market are:
AtriCure
Boston Scientific
St. Jude
Coherex Medical

Other prominent vendors included in this report are Lifetech Scientific, SentreHEART, and Occlutech.

Key questions answered in the report include
What will the market size and the growth rate be in 2019?
What are the key factors driving the global left atrial appendage closure market?
What are the key market trends impacting the growth of the global left atrial appendage closure market?
What are the challenges to market growth?
Who are the key vendors in the global left atrial appendage closure market?
What are the market opportunities and threats faced by the vendors in the global left atrial appendage closure market?
What are the trending factors influencing the market shares of the APAC, EMEA, and the Americas?
What are the key outcomes of the five forces analysis of the global left atrial appendage closure market?
Technavio also offers customization on reports based on specific client requirement.